Clinical Trial Update: A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130850 in Participants With Advanced Solid and Hematologic Tumors [Phase 1]

View source ↗

Summary

A first-in-human Phase 1 study evaluating the safety and tolerability of VVD-130850 in participants with advanced solid tumors and advanced hematologic malignan…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies
• Solid Tumors

Drugs mentioned

• VVD-130850

Snippet

Sponsor: Vividion Therapeutics, Inc. | Conditions: Advanced Solid Tumors, Advanced Hematologic Tumors | Phase 1 | Status: TERMINATED